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A rapid and reproducible method of inhibiting the expression of
specific genes in mosquitoes should further our understanding of
gene function and may lead to the identification of mosquito genes
that determine vector competence or are involved in pathogen
transmission. We hypothesized that the virus expression system
based on the mosquito-borne Alphavirus, Sindbis (Togaviridae),
may efficiently transcribe effector RNAs that inhibit expression of
a targeted mosquito gene. To test this hypothesis, germ-line-
transformed Aedes aegypti that express luciferase (LUC) from the
mosquito Apyrase promoter were intrathoracically inoculated with
a double subgenomic Sindbis (dsSIN) virus TEy3*2Jyanti-luc (Anti-
luc) that transcribes RNA complementary to the 5* end of the LUC
mRNA. LUC activity was monitored in mosquitoes infected with
either Anti-luc or control dsSIN viruses expressing unrelated anti-
sense RNAs. Mosquitoes infected with Anti-luc virus exhibited 90%
reduction in LUC compared with uninfected and control dsSIN-
infected mosquitoes at 5 and 9 days postinoculation. We demon-
strate that a gene expressed from the mosquito genome can be
inhibited by using an antisense strategy. The dsSIN antisense RNA
expression system is an important tool for studying gene function
in vivo.
The incidence of mosquito-borne diseases is increasing amonganimal and human populations worldwide (1). Reasons for
this increase are multifactorial and include the demise of mos-
quito control programs and increased insecticide resistance (2,
3). New tools and approaches to characterize gene function in
vectors are critical for developing innovative control strategies
for these diseases. For example, efforts to genetically alter the
ability of mosquitoes to transmit pathogens would be greatly
facilitated by understanding the role of genes that determine
vector competence and pathogen transmission (4–7).
One method of determining protein function of specific genes
is to inhibit gene expression and observe the biological conse-
quence. Gene function in Drosophila melanogaster often is
analyzed by transposon-mediated insertional inactivation of the
appropriate gene in a transgenic organism (8). Transformation
of the Aedes aegypti mosquito genome recently has been de-
scribed (9, 10), but germ-line transformation remains a laborious
and time-consuming procedure for characterization, mutagen-
esis, and expression of genes in mosquitoes. Additionally, the
complex life cycles of a number of medically important mosqui-
toes make routine transgenesis difficult.
Transient expression systems may more easily and rapidly
answer biological questions posed by researchers. Virus trans-
ducing systems that efficiently express genes of interest (GOIs)
in mosquitoes offer great potential for gene characterization.
The double subgenomic Sindbis (dsSIN) viruses, based on the
mosquito-borne virus Sindbis (SIN; Alphavirus; Togaviridae),
allow long-term, stable, cytoplasmic expression of GOIs in
mosquitoes (4, 11–13). SIN viruses are enveloped mosquito-
borne RNA viruses that are approximately 70 nm in diameter
(14). SIN virus replication and morphogenesis has been re-
viewed (14). dsSIN viruses are derived from fully infectious
cDNA clones of SIN viruses and have been genetically engi-
neered to express heterologous gene sequences in infected cells
(13, 15, 16). These engineered viruses differ from naturally
occurring SIN viruses because they contain a second subgenomic
RNA promoter element immediately to the 39 end of the
structural genes of the virus, which transcribes a second sub-
genomic mRNA of a GOI or a nontranslatable effector RNA
sequence. dsSIN viruses transcribe three mRNA species
(genomic, first subgenomic, and second subgenomic mRNAs) in
infected cells (Fig. 1), resulting in abundant expression of the
effector RNAs; dsSIN viruses can generate up to 105 effector
RNAsycell in infected mosquito cells by 96 hr postinfection (17).
dsSIN viruses already have been engineered that infect the
salivary glands of Ae. aegypti and efficiently express effector
RNAs complementary to specific gene sequences within the
genomes of yellow fever and dengue-2 viruses (Flaviviridae) (18,
19). Specific effector RNAs have been identified that profoundly
inhibit the replication of yellow fever and dengue-2 viruses in
salivary glands of Ae. aegypti, which prevents transmission of
these viruses. Antisense RNA interference with the replication
of these viruses is presumed to function by hybridization between
viral mRNA and the antisense RNA by Watson–Crick base
pairing (20–22). Gene expression may be inhibited by activation
of sequence-specific ribonucleases induced by double-stranded
RNA within the cell (23–25). Posttranscriptional inhibition of
endogenous gene expression also has been demonstrated in
eukaryotes, including plants (26), Drosophila (27, 28), and
Caenorhabditis elegans (24). Plant RNA viruses have been used
to inhibit expression of green fluorescent protein transiently
expressed in the nucleus of host plants (29).
To determine whether dsSIN viruses could be exploited to
target mRNAs transcribed from mosquito genes, we used a
transgenic line of Ae. aegypti that expresses a quantifiable
reporter gene (9). This line was developed by using a binary
Hermes transposable element system derived from Musca do-
mestica (9, 30, 31) to transform a white-eye mutant (khw) of Ae.
aegypti (32). The Hermes donor plasmid contained a phenotypic
marker gene, cinnabar, derived from Drosophila melanogaster
(33), and a reporter gene, luciferase (luc), regulated by the Ae.
aegypti Apyrase (Apy) promoter (10). Apyrase is a 59 nucleotidase
produced in the salivary glands of female mosquitoes, which
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: Anti-luc, TEy392Jyanti-luc; APY-LUC43, pH[cn]APY(1.6)LUC, line#43 trans-
genic Aedes aegypti; dsSIN, double subgenomic Sindbis virus; LUC (luc), luciferase; RLU,
relative light units; SIN, Sindbis.
§To whom reprint requests should be addressed. E-mail: bbeaty@cvmbs.colostate.edu.
The publication costs of this article were defrayed in part by page charge payment. This
article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C.
§1734 solely to indicate this fact.
PNAS u November 9, 1999 u vol. 96 u no. 23 u 13399–13403
M
IC
RO
BI
O
LO
G
Y
inhibits vertebrate host platelet aggregation during blood feed-
ing (34–36). In the transgenic mosquitoes, luciferase (LUC) is
expressed in the same developmental- and tissue-specific man-
ner as the endogenous Apy gene in wild-type Ae. aegypti (10, 34),
predominantly in the distal-lateral and medial lobes of the
salivary glands of female adult mosquitoes. A dsSIN virus,
designated TEy392Jyanti-luc (Anti-luc), was engineered to ex-
press a 595-base RNA sequence complementary to the 59 end of
the LUC mRNA. We report here the sequence-specific inhibi-
tion of LUC protein production in transgenic mosquito salivary
glands through expression of antisense RNA.
Materials and Methods
Construction of Anti-luc and Control dsSIN Viruses. The construction
of pTEy392J has been described (15, 16). pGEM-luc (Promega)
was digested with EcoRI and BamHI, and a 595-bp fragment
(position 1162–1757) was ligated into the EcoRIyBamHI site of
pBluescript II SK (Stratagene). pBSIISKy59luc was digested with
HindIII, and the ends were filled in with the Klenow fragment
of DNA polymerase I (E. coli) and religated to create an NheI
site (19). pBSIISKyNheIy59luc then was digested with XbaI and
NheI. The fragment was subcloned into the XbaI site of pTEy
392J, producing pTEy392Jyanti-luc (Fig. 1 A). The antisense
orientation of the insert was confirmed by restriction endonu-
clease digestion and PCR using primers derived from the virus
and insert sequence.
Suppression of gene expression by sense or antisense RNA in
both plant and animal cells depends on a high level of sequence
identity between the effector and target RNAs (18, 37). To
observe whether inhibition of LUC activity by dsSIN virus was
sequence specific, we included a nonhomologous antisense RNA
as the control virus. A dsSIN virus, TEy392Jyanti-D1GDD,
which expresses a 240-base sequence complementary to the
dengue-1 virus nonstructural protein 5 at the GDD motif
(position 9399–9641 of the dengue-1 virus genome), was used as
a control virus.
Generation of dsSIN Viruses. Recombinant virus was produced
from pTEy392J by linearization with XhoI, transcription from
the SP6 promoter, and electroporation into BHK-21 cells (38).
Tissue culture 50% infective dose (TCID50) of the virus, mea-
sured as log10 per ml, was determined by titration in triplicate in
baby hamster kidney 21 (BHK-21) cells. Viruses with TCID50 of
8.2–8.5 log10yml were used for inoculation in these experiments.
Mosquito Rearing. The generation and characterization of the
transgenic Ae. aegypti pH[cn]APY(1.6)LUC, line #43 (APY-
LUC43), has been described (10). APY-LUC43 generation 8
(G8) mosquitoes were obtained as eggs; G12 adults were used in
these experiments. Adult APY-LUC43 mosquitoes were main-
tained during the course of the experiments at 28°C and 80%
humidity, with 12-hr lightydark cycles, and sugar and water
provided ad libitum. In experiments requiring blood-fed mos-
quitoes, the preparation of blood and presentation of the blood
meal was performed as described (39).
Intrathoracic Inoculation of Mosquitoes. Adult female mosquitoes
were cold-anesthetized and intrathoracically injected by using a
Drummond 100-ml microcapillary needle that had been pre-
pared with a needle puller (Narishige, Tokyo). Approximately 1
ml of dsSIN virus (>105 infectious particles) in L-15 medium
containing 10% FBS and 1% antibiotics was injected into each
mosquito (19, 40).
Indirect Immunofluorescence Assay. Salivary glands from each
treatment group were dissected in water, mounted on acid-
washed slides in a droplet of diluted Elmer’s glue, dried, and
fixed in acetone for 10 min at 220°C (16). Infection of the
salivary glands with dsSIN virus was confirmed by indirect
immunofluorescence assay using a primary antibody that rec-
ognizes Sindbis E1 antigen diluted 1:200 (41) and visualized on
an Olympus BH-2 epifluorescence microscope.
LUC Activity Assay. Salivary glands were dissected in 0.15 M NaCl
buffer and stored at 270°C in 30 ml of lysis buffer (Promega).
Salivary glands were thawed at room temperature, sonicated in
an Aquasonics waterbath (model 75S, VWR Scientific) for 2 min
at 50°C, power level 5, then centrifuged (Hermle Z233M,
Wehningen, Germany) at 13,000 rpm briefly. LUC assays were
performed according to the manufacturer’s directions (Pro-
mega). Briefly, 20 ml of each sample was added to 100 ml of LUC
assay reagent. LUC activity was measured as relative light units
(RLU) by using a Turner TD-20e luminometer (Promega).
Apyrase Activity Assay. Apyrase activity was determined by using
the protocol of Ribeiro et al. (35) and an inorganic phosphorus
commercial kit (Sigma). Salivary glands were dissected in 0.15 M
NaCl and transferred to 100 ml of 10 mM TriszCl (pH 7.5).
Salivary glands were homogenized in an Aquasonics waterbath
(VWR Scientific) for 2 min at 50°C, power level 5, then
centrifuged at 13,000 rpm for 1 min. Five microliters of salivary
gland homogenate was added to 95 ml of reaction medium (100
mM TriszHCl buffer (pH 9.0), 200 mM NaCl, 10 mM CaCl2, and
20 mM ADP sodium salt) and incubated at 37°C for 30 min. The
reaction was stopped by adding 25 ml of ammonium molybdate
in 2.5 N sulfuric acid (Sigma). The amount of inorganic phos-
phate released was visualized by adding 3 ml of Fiske &
Fig. 1. (A) pTEy392Jyanti-luc linearized by digestion with XhoI. A 595-base
fragment from the 59 end of the Luc gene was ligated into the multiple cloning
site behind the second subgenomic promoter in antisense orientation. (B) The
three predicted species of viral RNA transcripts expressed in mosquito cells.
Viral nonstructural proteins are translated directly from genomic RNA. Struc-
tural protein mRNA is transcribed from the negative-sense strand at the
subgenomic promoter; the heterolous antisense LUC segment also is tran-
scribed. Antisense LUC mRNA also is transcribed from the negative-sense
strand at the second subgenomic promoter. NS, nonstructural; S, structural;
NCR, noncoding region.
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Subbarow reducing reagent (Sigma) and determined by using a
450 Plate Reader (Bio-Rad) at 665 nm. Apyrase activity was
calculated as the total amount of monophosphate released per
microgram of salivary gland protein.
Total Protein Concentration. Salivary gland samples assayed for
LUC and apyrase activity also were assayed for protein concen-
tration by using the Pierce-Coomassie Plus Protein assay reagent
in a 96-well plate according to the manufacturer’s instructions.
Protein concentration was determined by using a 450 Plate
Reader at 595 nm compared with BSA standards.
Western Blot Assay. Salivary glands were dissected in 0.15 M NaCl
then transferred to a tube containing 12 ml of nonreducing
loading buffer. Homogenization consisted of three cycles of
freeze-thawing and boiling for 2 min. One complete salivary
gland was loaded per lane and proteins were separated on a 10%
SDSyPAGE 1-mm gel (NOVEX, Hercules, CA) run at 150 mV
for 1 hr. Proteins were transferred to a nitrocellulose membrane
(Trans-blot, Bio-Rad) in 10% methanol transfer buffer at 200
mA for 3 hr. Proteins were detected by using the ECL-Western
blotting kit (Amersham Pharmacia) according to the manufac-
turer’s instructions, except that PBS-0.05% NP-40 was used for
blotting and all washes. A polyclonal rabbit anti-apyrase anti-
body raised to recombinant apyrase peptide diluted 1:20,000
detected the 68-kDa apyrase protein (42). The membrane was
stripped and reprobed with a polyclonal rabbit anti-D7 antibody
diluted 1:2,000, which detected the 37-kDa D7 protein (43).
Amersham anti-rabbit horseradish peroxidase secondary anti-
body, diluted 1:1000, was used as secondary antibody. The
membrane was exposed to Kodak X-Omat AR (VWR Scientific)
x-ray film for 2 sec for both detections. Total salivary gland
protein was detected by rinsing the membrane twice in PBS-
0.05% NP-40 then incubating with 50 ml of colloidal gold
(Bio-Rad) for 1 hr.
Virus Assays of Infected Mosquitoes. Virus titrations were per-
formed to confirm virus infection. Heads and abdomens in L-15
diluent were triturated with a pestle then passed through a 2-mm
pore-size filter, as described (16). Virus titers were determined
by end point dilution assay in triplicate in Vero cells (44).
Statistical Analysis. Because of the variation of LUC protein
expression among individual mosquitoes within a treatment
group, the SDs were larger, in some cases, than the mean. To
normalize the data points so that treatment groups could be
compared, ANOVA and contrast statements of the sample
values were calculated from log10 of RLU values, by using the SAS
6.12 statistical program.
Results
Anti-luc Virus Characterization. Transcription of the three viral
mRNA species of Anti-luc virus (Fig. 1) was confirmed by
Northern blot analysis of infected Aedes albopictus C6y36 cells
(data not shown) (19). Mosquito infection was confirmed by
determining viral titers in carcasses (Table 1). Mean titers
ranged from 4.0 to 5.6 log10 TCID50 per mosquito. In addition,
SIN antigen was detected in all lobes of the salivary glands of
mosquitoes infected with Anti-luc and control virus at 2 and 10
days postinoculation (Fig. 2 B and C). This finding confirmed
that the dsSIN viruses infect the same tissue of the salivary gland
that expresses LUC in the transgenic mosquitoes, specifically the
distal-lateral and medial lobes (10).
LUC Expression in APY-LUC43 Mosquitoes Infected with Anti-luc Virus.
LUC activity was assayed in dissected salivary glands of exper-
imental mosquitoes. Female mosquitoes that had eclosed less
Fig. 2. Indirect immunofluorescence assay showing APY-LUC43 female mos-
quito salivary glands (A) 10 days after intrathoracic inoculation with saline, (B)
48 hr after inoculation with Anti-luc virus, and (C) 10 days after inoculation
with Anti-luc virus. SIN virus infection is confirmed in B and C by use of a
primary antibody that recognizes SIN E1 protein (41). DL, distal-lateral lobe; M,
medial lobe; PL, proximal-lateral lobe. Magnifications: A, 3200; B and C, 3100.
Table 1. LUC activity in salivary glands of transgenic
(APY-LUC43) mosquitoes
n
(% survival)
Average
TCID50
(log10/ml)
Mean (SE)
RLU/mg
protein
P
value*
5 days postinoculation
Uninoculated 20 (78) NI 272 (142)
Control virus 19 (73) 5.6 210 (125)
Anti-luc virus 20 (78) 5.2 18 (9) 0.001
9 days postinoculation
Uninoculated 17 (83) NI 21 (4)
Control virus 14 (73) 4.5 14 (4)
Anti-luc virus 16 (70) 4.0 3 (1) 0.0001
NI, not infected.
*LUC activity (RLU/mg protein) in Anti-luc virus-infected vs. uninfected and
control virus-infected mosquitoes as calculated by contrast statement.
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than 24 hr earlier were cold-anesthetized and intrathoracially
injected with Anti-luc virus or control virus. Uninoculated
controls were cold-anesthetized only. Salivary glands were col-
lected at 5 and 9 days postinoculation. The 9-day group was
blood-fed on day 6.
LUC activity in dissected salivary glands was measured and
standardized to the total protein of the salivary gland sample
(average protein concentration per salivary gland: 2.2 mg in
uninfected, 2.6 mg in control virus, and 1.8 mg in Anti-luc
virus-infected mosquitoes). Mean LUC activity at 5 days posti-
noculation was 272 RLUymg protein in uninoculated controls
and 210 RLUymg protein in mosquitoes infected with control
virus, compared with 18 RLUymg protein in mosquitoes infected
with Anti-luc virus (Table 1). Mean LUC activity at 9 days was
21, 14, and 3 RLUymg protein for uninfected, control virus-
infected, and Anti-luc virus-infected mosquitoes, respectively.
Data were transformed to log10 and analyzed for evidence of
LUC inhibition. LUC activity in Anti-luc-infected mosquitoes
was reduced .90% compared with uninfected controls at both
5 (0.7 vs. 2.0 log10 RLUymg protein; P 5 0.0001) and 9 days (20.7
vs. 1.2 log10 RLUymg protein; P 5 0.0001) postinfection (Fig. 3).
Mean LUC activity in salivary glands of virus controls and
uninfected controls was not significantly different at 5 days (1.7
vs. 2.0 log10 RLUymg protein; P 5 0.17) or 9 days (0.9 vs. 1.2 log10
RLUymg protein; P 5 0.2) postinfection (Fig. 3).
Apyrase and Western Blot Assays. Mean salivary gland apyrase
activity did not differ statistically at 5 or 9 days postinfection
between uninfected mosquitoes and those infected with Anti-luc
virus (Table 2). Western blot assay showed comparable amounts
of apyrase and D7 proteins in Anti-luc virus-infected and
uninfected salivary glands (Fig. 4 A and B). In addition, total
protein profiles and concentrations did not differ between
Anti-luc-infected and uninfected salivary glands (Fig. 4C).
Discussion
LUC production in APY-LUC43 mosquitoes was significantly
inhibited by Anti-luc virus infection at both 5 and 9 days. LUC
activity from dissected salivary glands was measured and stan-
dardized to the total salivary gland protein to eliminate the effect
variable salivary gland size might have on LUC expression.
Expression was inhibited .10-fold compared with uninfected
and virus controls at both 5 and 9 days postinfection (Table 1 and
Fig. 3). The difference in LUC expression between mosquitoes
that were either uninfected or infected with control virus was not
statistically significant (Table 1 and Fig. 3). In a previous
experiment using total thoraces, LUC expression in mosquitoes
infected with control virus increased 2-fold over uninoculated
controls at 5 (56 vs. 22 RLU) and 9 (51 vs. 21 RLU) days
postinoculation. Although the reason for this difference is
currently unknown, it is important to note that at no time did the
control dsSIN virus depress LUC expression. There were no
apparent pathogenic effects of infection by the dsSIN viruses, as
mosquitoes infected with control virus had survival rates similar
to uninfected controls (Table l), similar to previous observations
(45).
In addition, enzyme activity and concentrations of other
proteins produced in the same salivary gland tissue did not differ
in Anti-luc virus-infected and uninfected mosquitoes. Apyrase
activity was not significantly different between uninfected mos-
quitoes and those infected with Anti-luc virus (Table 2). Apyrase
protein, as measured by Western blot assay, was abundant in
both treatment groups (Fig. 4B). Similarly, D7, a female-specific
salivary gland protein produced in the same tissue as apyrase and
LUC, was present in equivalent amounts in both uninfected and
Anti-luc-infected mosquitoes (Fig. 4A). Finally, the total protein
profile and concentrations were also equivalent in the two
groups (Fig. 4C). Thus, the dsSIN system would seem to be a
useful tool for characterizing salivary gland genes.
The individual variability of LUC expression is a confounding
factor in the experiments. LUC expression in uninoculated
controls could vary by as much as 100-fold (data not shown). The
APY-LUC43 line was derived from one male and 10 females,
and some genetic variability could account for the wide range of
LUC expression, which has been noted since establishment of
the line (C.J.C. and A.A.J., unpublished data). Alternatively, the
surrounding chromatin structure at the genomic site of insertion
may influence Apy promoter activity. Environmental factors
Fig. 3. Mean log10 LUC activity, measured as RLU standardized to total
protein concentration of the salivary glands, in APY-LUC43 mosquitoes 5 and
9 days after intrathoracic injection with either Anti-luc virus or control virus.
Uninoculated control mosquitoes were cold-anesthetized only.
Fig. 4. Western blot assay showing (A) the 37-kDa D7 protein, (B) the 68-kDa
apyrase protein, and (C) total protein stained from the nitrocellulose mem-
brane. Lanes 1, one pair of uninfected salivary glands; lanes 2, one pair of
salivary glands infected with Anti-luc virus for 5 days.
Table 2. Apyrase activity in salivary glands
5 day Mean 6 SE N 9 day Mean 6 SE N
Uninfected 252 6 61 6 252 6 59 7
Anti-luc virus 182 6 49 7 272 6 57 5
Apyrase activity was measured as the amount of monophosphate produced
per microgram of salivary gland protein (PO4/mg protein). The 9-day mosqui-
toes were blood-fed on day 6.
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such as nutritional status and body size upon eclosion also could
contribute to variability in apyrase promoter activity. We were
unable to analyze the transcriptional activity of LUC, as LUC
mRNA is not detectable by Northern blot analysis (10).
LUC expression was measured in individual mosquitoes. The
majority of mosquitoes infected with Anti-luc virus had approx-
imately 1% the LUC activity of controls. However, in a few
Anti-luc virus-infected individuals, LUC activity approached
control levels (data not shown), which resulted in a group mean
of 10% LUC activity compared with controls. It is possible that
the lack of inhibition of LUC expression seen in these few
Anti-luc virus infected individuals is caused by less than 100%
infection of the salivary gland cells expressing LUC. Once a cell
is infected the amount of antisense RNA transcribed by the
dsSIN virus is probably sufficient to inhibit LUC expression.
dsSIN viruses have been shown to produce as many as 105
transcriptsycell in Aedes albopictus C6y36 cells (17), and LUC
mRNA is undetectable in the transgenic mosquito salivary
glands (10). Future experiments should test the ability of the
dsSIN system to inhibit expression of more abundantly expressed
endogenous mosquito genes.
Despite the individual variability of LUC expression and the
few cases of breakthrough expression in mosquitoes infected
with Anti-luc virus, LUC expression in APY-LUC43 mosquitoes
was inhibited .90% by Anti-luc virus infection. Thus intratho-
racic injection of mosquitoes with Anti-luc virus is an effective
and specific method for inhibiting gene expression in vivo.
We have shown inhibition of a gene expressed from the
mosquito genome using antisense RNA delivered by the dsSIN
virus expression system. Works in progress include design of a
dsSIN vector that can orally infect mosquitoes (46), which would
reduce possible deleterious effects from the inoculation. Future
targets for gene expression inhibition include the Apy gene itself,
or an inducible endogenous gene, such as late trypsin in the
midgut (47). dsSIN virus infection, and thus antisense transcript
production, could be established before induction of the trypsin
gene by blood feeding. Inhibition of gene expression in vivo will
increase our knowledge of mosquito biology and further our
understanding of the dynamic interactions between the pathogen
and the mosquito vector.
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